Reply to thread

Not sure what the point is of calling out directors. They have a job that is in flux as much as ours.  They prob understand there are no guarantees that anyone will have a job in 6 months and need to deliver sales results. This product miss d its chance. With the new B&L drug, new tarsus drug, and generic getting more usage xiidra is DOA and everyone knows it. if you were smart you’d get out and not wait for severance.